UMN Pharma Inc. Announces Nonconsolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Nonconsolidated Earnings Guidance for the Year Ending December 31, 2017
For the year ending December 31, 2017, on nonconsolidated basis, the company forecasts net sales to be JPY 153 million, operating loss to be JPY 512 million, ordinary loss to be JPY 167 million and net loss to be JPY 170 million or JPY 13.96 per share.